BREAKING
NVIDIA (NVDA) eyes China AI chip re-entry as export licensing shifts to case-by-case review 3 days ago Qualcomm (QCOM) authorizes $20B stock repurchase program, raises quarterly dividend to $0.92 3 days ago UP Fintech Holding Limited Reports Strong 2025 Results 3 days ago FedEx (FDX) Q3 Earnings Crush Estimates: EPS of $5.25 Beats by 27% on $24B Revenue 3 days ago Cato Corporation 2025 Financial Results Summary 3 days ago GROY Posts Breakeven Q4 Earnings, Beating Estimates by 100% as Revenue Grows 34.2% YoY to $4.5M 3 days ago York Space Systems (YSS) Posts -$0.24 EPS vs. -$0.18 Est., Revenue Soars to $105.3M 3 days ago Scholastic (SCHL) Q3 Loss Narrows to $0.15/Share vs $0.36 Estimate, Revenue Misses at $329.1M 3 days ago Curis (CRIS) EPS Soars 210.8% to $1.23, But Revenue Plunges 67.1% to $1.1M 3 days ago Eton Pharmaceuticals (ETON) Q4 Revenue Surges 82.9% YoY to $21.3M, EPS Climbs 266.7% 3 days ago NVIDIA (NVDA) eyes China AI chip re-entry as export licensing shifts to case-by-case review 3 days ago Qualcomm (QCOM) authorizes $20B stock repurchase program, raises quarterly dividend to $0.92 3 days ago UP Fintech Holding Limited Reports Strong 2025 Results 3 days ago FedEx (FDX) Q3 Earnings Crush Estimates: EPS of $5.25 Beats by 27% on $24B Revenue 3 days ago Cato Corporation 2025 Financial Results Summary 3 days ago GROY Posts Breakeven Q4 Earnings, Beating Estimates by 100% as Revenue Grows 34.2% YoY to $4.5M 3 days ago York Space Systems (YSS) Posts -$0.24 EPS vs. -$0.18 Est., Revenue Soars to $105.3M 3 days ago Scholastic (SCHL) Q3 Loss Narrows to $0.15/Share vs $0.36 Estimate, Revenue Misses at $329.1M 3 days ago Curis (CRIS) EPS Soars 210.8% to $1.23, But Revenue Plunges 67.1% to $1.1M 3 days ago Eton Pharmaceuticals (ETON) Q4 Revenue Surges 82.9% YoY to $21.3M, EPS Climbs 266.7% 3 days ago
ADVERTISEMENT
Market News

Humana (NYSE: HUM): Q4 2019 Earnings Snapshot

— Humana Inc. (NYSE: HUM) reported its fourth-quarter 2019 adjusted earnings of $2.28 per share versus $2.20 per share expected. — Revenues grew by 15% to $16.3 billion versus $16.19 billion expected. — The unadjusted earnings jumped by 36% driven by the solid performance of medicare advantage business and healthcare services segment with further benefit […]

February 5, 2020 1 min read
Alphastreet Vertex Pharma Q4 2025 Earnings Results

— Humana Inc. (NYSE: HUM) reported its fourth-quarter 2019 adjusted earnings of $2.28 per share versus $2.20 per share expected. — Revenues grew by 15% to $16.3 billion versus $16.19 billion expected. — The unadjusted earnings jumped by 36% driven by the solid performance of medicare advantage business and healthcare services segment with further benefit […]

— Humana Inc. (NYSE: HUM) reported its fourth-quarter 2019 adjusted earnings of $2.28 per share versus $2.20 per share expected.

— Revenues grew by 15% to $16.3 billion versus $16.19 billion expected.

Earnings Update by AlphaStreet

— The unadjusted earnings jumped by 36% driven by the solid performance of medicare advantage business and healthcare services segment with further benefit from achieving significant operating cost efficiencies in 2019 as a result of previously implemented productivity initiatives.

— Revenues from the retail segment increased by 18% while that from group and specialty segment decreased by 2%. Revenue from healthcare services segment grew by 8%.

— Looking ahead into the full year 2020, the company expects unadjusted earnings of $17.76-18.26 per share and adjusted earnings of $18.25-18.75 per share. The consensus estimates EPS of $18.63.

— Humana expects 2020 to be another good year for the company with a solid top and bottom-line growth notwithstanding the return of the health insurance industry fee.

— The company reaffirmed 2020 individual Medicare Advantage membership growth outlook of 270,000 to 330,000 members, representing 7.5-9.2% growth over 2019.

— The company revised fiscal 2020 stand-alone PDP membership guidance to a decline of about 550,000 members from the previous expectation of about 600,000 member decline.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

ADVERTISEMENT